Jonathan Spergel

Children's Hospital of Philadelphia, United States of America

Jonathan M. Spergel, M.D., Ph.D received his medical and graduate education at the Mount Sinai School of Medicine and completed his pediatric residency at Yale-New Haven Hospital. His clinical and post-graduate research training in Allergy and Immunology were completed at Children’s Hospital, Harvard Medical School, Boston, MA. Dr. Spergel is Board Certified in Pediatrics and Allergy and Immunology.

Academix positions
- Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine
- Chief of the Allergy Section at Children’s Hospital of Philadelphia

Research interests
- the fields of asthma, atopic dermatitis and food allergies

Other information
- Fellow of the American Academy of Allergy Asthma and Immunology
- Fellow of the American College of Allergy, Asthma and Immunology
- Fellow of the American Assoc of Pediatrics
- Fellow of the Philadephia College of Physicians and others.
- Dr. Spergel has published over 40 articles in his field.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Dermatology > Atopic Dermatitis & Other Forms of Eczema (since 27 March 2007)

All recent recommendations

• 3.0
  3-Yr-Follow-Up of Topical Corticosteroid Treatment for Eosinophilic Esophagitis in Adults.
  Recommended by Jonathan Spergel
  
• 6.6
  Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
  Recommended by Jonathan Spergel, Norito Katoh, Masutaka Furue with Hidehisa Saeki
  
• 3.0
  Eosinophilic Esophagitis: Analysis of Food Impaction and Perforation in 251 Adolescent and Adult Patients.
  Recommended by Jonathan Spergel
  
• 4.8
  Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas.
  Recommended by Anna Bruckner, Jonathan Spergel
  
• 3.0
  IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.
  Recommended by Jonathan Spergel
  
• 5.0
  In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.
  Recommended by Jonathan Spergel, Eric Simpson, Alan Irvine with Caitriona Hackett, Devendra Agrawal
  
• 6.0
  Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study.
  Recommended by Jonathan Spergel
  
• 3.0
  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.
  Recommended by Jonathan Spergel
  
• 4.8
  Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis.
  Recommended by Masutaka Furue, Jonathan Spergel
  
• 4.8
  Cytokine modulation of atopic dermatitis filaggrin skin expression.
  Recommended by Jonathan Spergel, Eric Simpson
  
• 3.0
  Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.
  Recommended by Jonathan Spergel